# SA4503 8-Week Study in Major Depressive Disorder (MDD)

> **NCT00551109** · PHASE2 · COMPLETED · sponsor: **M's Science Corporation** · enrollment: 150 (estimated)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** placebo
- **DRUG:** SA4503 Low
- **DRUG:** SA4503 High

## Key facts

- **NCT ID:** NCT00551109
- **Lead sponsor:** M's Science Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2008-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2008-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00551109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00551109, "SA4503 8-Week Study in Major Depressive Disorder (MDD)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00551109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*